On January 25, 2016, the board of directors of AXIM Biotechnologies, Inc. appointed Seth Yakatan to the company's Advisory Board. Seth Yakatan brings more than 24 years of experience as a corporate finance professional, actively supporting small cap and major companies in achieving corporate, financing and asset monetization objectives through the successful structuring and management of strategic transactions and investments totaling more than several billion dollars in value.